GlaxoSmithKline (NYSE:GSK), one of the leading British pharmaceutical companies, had not witnessed a great year in 2014. The United States payers declined to pay for the reimbursement of the respiratory drug of the company. The sales of the company fell greatly, especially in its Breo Ellipta and Anoro segment.
Hey, check out all the research scientist jobs. Post your resume today!
